05/27/2016
William L. Lombardi, MD; Khaldoon Alaswad, MD; Dimitrios Karmpaliotis, MD, PhD; J. Aaron Grantham, MD; Nicholas J. Lembo, MD; Craig A. Thompson, MD, MMSc; Colby R. Ayers, MS; Phuong-Khanh J. Nguyen-Trong, MD; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Subhash Banerjee, MD, FSCAI; Aris Karatasakis, MD; David E. Kandzari, MD; Barbara Anna Danek, MD; Judit Karacsonyi, MD, PhD; Michele Roesle, RN, BSN, MD; Bavana V. Rangan, BDS, MPH, MD
The use of SVGs for retrograde native vessel CTO-PCI has received limited study. We reviewed the medical records and coronary angiograms of retrograde CTO-PCIs performed through an SVG at 4 U.S. institutions between 2012 and 2013.
The use of SVGs for retrograde native vessel CTO-PCI has received limited study. We reviewed the medical records and coronary angiograms of retrograde CTO-PCIs performed through an SVG at 4 U.S. institutions between 2012 and 2013.
The use of SVGs for retrograde...